CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

David Wolinsky - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

David Wolinsky

OPENALEX: A5063809928↗ORCID: 0000-0002-6321-7333↗

Affiliations

Organizations

Johns Hopkins Medicineauthorship · US Johns Hopkins Universityauthorship · US

Public evidence

2 connected articles

The acute and chronic pharmacokinetics and pharmacodynamics of oral cannabidiol with and without low doses of delta-9-tetrahydrocannabinol.2026 · Europe PMC Safety of Co-Administered Cannabidiol (CBD) and alcohol: a Phase I study.2026 · PubMed Central Open Access

Registered research

Connected studies

Safety of Co-Administered CHI-554 and Alcoholnct05317507

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.